Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma

Laboratory Investigation

Volumn 81, Issue 10, 2001, Pages 1385-1396

  To, Y ^a   Dohi, M ^a   Tanaka, R ^a   Sato, A ^a   Nakagome, K ^a   Yamamoto, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTERLEUKIN 4; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; OVALBUMIN;

AEROSOL; ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; ASTHMA; BRONCHITIS; BRONCHUS HYPERREACTIVITY; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; HISTOLOGY; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 0034774796     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780352     Document Type: Article

References (60)

1. Interleukin-10 regulation in normal subjects and patients with asthma
2. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice
3. Association of asthma with serum IgE levels and skin prick test reactivity to allergens
4. IL-4 -independent induction of airway hyperresponsiveness by Th2, but not Th1 cells
5. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
6. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
7. Depletion of circulating allergen-specific TH2 T lymphocytes after allergen exposure in asthma
8. Nuclear factor-IL-6 activates the human IL-4 promoter in T cells
9. T-lymphocytes regulate genetically determined airhyperresponsiveness in mice
10. Bronchial responsiveness to mite allergen in atopic dermatitis without asthma
11. Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma
12. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model
13. Early life origins of asthma
14. Requirement for IL-13 independently of IL-4 in experimental asthma
15. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
16. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
17. IgE-independent MHC-restricted T cell peptide epitope-induced late asthmatic response
18. Blockade of CD49d (α4 integrin) on pulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
19. The importance of leukotrienes in airway inflammation in a mouse model of asthma
20. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4
21. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice
22. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
23. Aeroallergen-induced eosinophilic inflammation, lung damage, and airway hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
24. The role of allergy in the development of asthma
25. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma
26. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: Evidence against "asthma being a distinct immunological entity"
27. A plethysmograph for long-term measurement of ventilation in unrestrained animals
28. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model
29. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation
30. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
31. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
32. Allergen-induced cytokine production in atopic disease and its relationship to disease severity
33. Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig
34. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation
35. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma
36. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation
37. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity
38. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation
39. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma
40. Immune mechanisms of smooth muscle hyperreactivity in asthma
41. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen
42. Relationship between airway responsiveness and serum IgE in children with asthma and in apparently normal children
43. Effect of inhaled interleukin-4 on airway hyperreactivity asthmatics
44. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
45. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice
46. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: A double-blind randomized study
47. Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge
48. Repeated intratracheal challenge with particulate antigen modulates murine lung cytokines
49. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model
50. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma
51. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia
52. Interleukin-13: Central mediator of allergic asthma
53. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents
54. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics
55. The transcription factor NF-ATc 1 regulates lymphocyte proliferation and Th2 cytokine production
56. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene
57. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3
58. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response
59. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: Inhibition of eosinophilic inflammation and bronchial hyperresposiveness
60. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production